Dermapharm Holding SE Defensive Interval Ratio
Dermapharm Holding SE defensive interval ratio. Dermapharm Holding SE (DMP) has a Defensive Interval Ratio of 155 days as of March 2026. Defensive assets of €165.73 Million (cash €-, short-term investments €28.06 Million, receivables €137.66 Million) cover 155 days of daily cash needs of €1.07 Million/day. Explore Dermapharm Holding SE long-term investment allocation to see how much of total assets are deployed in long-term investments.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Dermapharm Holding SE (2013–2025)
Defensive interval ratio of Dermapharm Holding SE from 2013 to 2025. This chart shows how Dermapharm Holding SE's Defensive Interval Ratio has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 155 days, meaning defensive assets of €165.73 Million can fund 155 days of operations without new revenue. Read debt load of Dermapharm Holding SE for a breakdown of total debt and financial obligations.
Dermapharm Holding SE Defensive Interval Ratio by Year (2013–2025)
Dermapharm Holding SE defensive interval ratio by year from 2013 to 2025. The table below presents the year-by-year Defensive Interval Ratio for Dermapharm Holding SE from 2013 to 2025, covering 13 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Dermapharm Holding SE assets under control.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 130 days | €122.11 Million | €939.53K/day | €- | €735.00K | ▲ +12 days |
| 2024 | 118 days | €105.52 Million | €895.66K/day | €- | €511.00K | ▼ -118 days |
| 2023 | 236 days | €254.91 Million | €1.08 Million/day | €158.68 Million | €818.00K | ▼ -204 days |
| 2022 | 440 days | €262.58 Million | €596.69K/day | €150.99 Million | €11.44 Million | ▼ -144 days |
| 2021 | 585 days | €249.20 Million | €426.34K/day | €161.38 Million | €11.74 Million | ▲ +99 days |
| 2020 | 486 days | €176.82 Million | €364.03K/day | €120.27 Million | €1.04 Million | ▼ -116 days |
| 2019 | 601 days | €168.74 Million | €280.61K/day | €114.71 Million | €1.06 Million | ▼ -16 days |
| 2018 | 618 days | €247.69 Million | €401.09K/day | €212.47 Million | €1.10 Million | ▲ +123 days |
| 2017 | 495 days | €109.25 Million | €220.76K/day | €6.24 Million | €400.00K | ▲ +274 days |
| 2016 | 221 days | €70.00 Million | €316.23K/day | €3.82 Million | €30.00K | ▼ -134 days |
| 2015 | 356 days | €59.98 Million | €168.69K/day | €- | €29.00K | ▲ +49 days |
| 2014 | 307 days | €81.60 Million | €265.85K/day | €- | €120.00K | ▲ +72 days |
| 2013 | 235 days | €108.63 Million | €462.08K/day | €- | €120.00K | — |